Exelixis (EXEL) Consolidated Net Income (2010 - 2026)
Exelixis (EXEL) reported Consolidated Net Income of $212.05 million for Q2 2027, up 14.7% from $184.85 million a year earlier and up 0.8% from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) Consolidated Net Income (2010 - 2026) Analysis & Trends
Over the twelve months ended Jul 3, 2026, Exelixis' Consolidated Net Income came in at $860.62 million, up 42.9% year-over-year; for FY2026, it was $782.57 million, up 50.1% from FY2025.
- Consolidated Net Income has a five-year compound annual growth rate of 27.6% (FY2021 to FY2026).
- By year, Consolidated Net Income came in at $521.27 million in FY2025, $207.77 million in FY2023 (+14.0%) and $182.28 million in FY2022 (-21.1%).
- Five-year quarterly Consolidated Net Income spans a low of $37.32 million in Q1 2025 and a high of $244.53 million in Q4 2026.
- Year over year, Consolidated Net Income has now increased in each of the last four quarters, with growth averaging 82.5% over the last six quarters.
- Per Business Quant data, the three quarters before Q2 2027 came in at $210.47 million (Q1 2027), $244.53 million (Q4 2026) and $193.58 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Exelixis | 14.53 Bn | 10.87 Bn | 608.03 Mn | 212.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 212.05 Mn |
| Apr 3, 2026 | 210.47 Mn |
| Jan 2, 2026 | 244.53 Mn |
| Oct 3, 2025 | 193.58 Mn |
| Jul 4, 2025 | 184.85 Mn |
| Apr 4, 2025 | 159.62 Mn |
| Jan 3, 2025 | 139.86 Mn |
| Sep 27, 2024 | 117.97 Mn |
| Jun 28, 2024 | 226.12 Mn |
| Mar 29, 2024 | 37.32 Mn |
| Dec 29, 2023 | 85.52 Mn |
| Sep 29, 2023 | 1.04 Mn |
| Jun 30, 2023 | 81.18 Mn |
| Mar 31, 2023 | 40.03 Mn |
| Dec 30, 2022 | -30.17 Mn |
| Sep 30, 2022 | 73.21 Mn |
| Jul 1, 2022 | 70.67 Mn |
| Apr 1, 2022 | 68.57 Mn |
| Dec 31, 2021 | 95.17 Mn |
| Oct 1, 2021 | 38.20 Mn |
API Access
Exelixis Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();